Abstract
IgA nephropathy is one of the most common causes of glomerulonephritis in the world. Proliferative and crescentic forms of IgA are found in up to 30% of cases and are associated with nephrotic-range proteinuria, accelerated hypertension, and accelerated decline toward ESRD. Despite its prevalence and clinical importance, there is no unifying nomenclature or consensus for the treatment of specific histologic subgroups. As a consequence, the development of clinically effective treatment regimens for IgA nephropathy have lagged behind other, less common forms of glomerulonephritis. Herein is reviewed the pathogenesis and histologic subtypes of IgA nephropathy and how conventional and immunosuppressive therapies have an impact on renal survival and recurrence rates. The use of known clinical risk factors for disease progression in conjunction with specific histologic features can be a guide to both induction and consolidation therapies for individual patients with IgA nephropathy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1054-1061 |
| Number of pages | 8 |
| Journal | Clinical Journal of the American Society of Nephrology |
| Volume | 2 |
| Issue number | 5 |
| DOIs | |
| State | Published - Sep 1 2007 |
Fingerprint
ASJC Scopus subject areas
- Epidemiology
- Critical Care and Intensive Care Medicine
- Nephrology
- Transplantation
Cite this
Idiopathic IgA nephropathy : Pathogenesis, histopathology, and therapeutic options. / Tumlin, James A.; Madaio, Michael P.; Hennigar, Randolph.
In: Clinical Journal of the American Society of Nephrology, Vol. 2, No. 5, 01.09.2007, p. 1054-1061.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Idiopathic IgA nephropathy
T2 - Pathogenesis, histopathology, and therapeutic options
AU - Tumlin, James A.
AU - Madaio, Michael P.
AU - Hennigar, Randolph
PY - 2007/9/1
Y1 - 2007/9/1
N2 - IgA nephropathy is one of the most common causes of glomerulonephritis in the world. Proliferative and crescentic forms of IgA are found in up to 30% of cases and are associated with nephrotic-range proteinuria, accelerated hypertension, and accelerated decline toward ESRD. Despite its prevalence and clinical importance, there is no unifying nomenclature or consensus for the treatment of specific histologic subgroups. As a consequence, the development of clinically effective treatment regimens for IgA nephropathy have lagged behind other, less common forms of glomerulonephritis. Herein is reviewed the pathogenesis and histologic subtypes of IgA nephropathy and how conventional and immunosuppressive therapies have an impact on renal survival and recurrence rates. The use of known clinical risk factors for disease progression in conjunction with specific histologic features can be a guide to both induction and consolidation therapies for individual patients with IgA nephropathy.
AB - IgA nephropathy is one of the most common causes of glomerulonephritis in the world. Proliferative and crescentic forms of IgA are found in up to 30% of cases and are associated with nephrotic-range proteinuria, accelerated hypertension, and accelerated decline toward ESRD. Despite its prevalence and clinical importance, there is no unifying nomenclature or consensus for the treatment of specific histologic subgroups. As a consequence, the development of clinically effective treatment regimens for IgA nephropathy have lagged behind other, less common forms of glomerulonephritis. Herein is reviewed the pathogenesis and histologic subtypes of IgA nephropathy and how conventional and immunosuppressive therapies have an impact on renal survival and recurrence rates. The use of known clinical risk factors for disease progression in conjunction with specific histologic features can be a guide to both induction and consolidation therapies for individual patients with IgA nephropathy.
UR - http://www.scopus.com/inward/record.url?scp=34548827626&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34548827626&partnerID=8YFLogxK
U2 - 10.2215/CJN.04351206
DO - 10.2215/CJN.04351206
M3 - Review article
C2 - 17702711
AN - SCOPUS:34548827626
VL - 2
SP - 1054
EP - 1061
JO - Clinical Journal of the American Society of Nephrology
JF - Clinical Journal of the American Society of Nephrology
SN - 1555-9041
IS - 5
ER -